KoVax
Jerusalem
About KoVax
KoVax Ltd. was established in 2003 in order to develop, manufacture and market a vaccine to eradicate fish diseases. Kovax is the only company in the world that produced and markets an efficient and safe vaccine against CyHV3 (KHV) disease.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Website: kovax.co.il
- Phone: +972-2-5865593
Canonical: https://fsome.com/organization/kovax-2261515 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.